# Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Source: https://onco.cc/trials/nct02598349/  
OnCo record `nct02598349` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of capecitabine in pancreatic cancer, run by Proton Collaborative Group, now recruiting.

## Summary

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas is a phase 2, interventional study registered as NCT02598349 by Proton Collaborative Group, with a registry enrolment figure of 60 participants, started 2016-04 and due to reach its primary completion in 2039-10. Interventions recorded: Proton Radiation; Capecitabine; Surgical resection. Conditions listed: Pancreatic Cancer. Primary outcome: Overall survival at 12 months after radiation therapy. Pancreatic eligibility wording from the registry: "* Biopsy proven unresectable adenocarcinoma of the pancreas". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT02598349
- Phase: 2
- Setting: A Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma
- Sponsor: Proton Collaborative Group
- Enrolled: 60

## Sources

- ClinicalTrials.gov NCT02598349: https://clinicaltrials.gov/study/NCT02598349

## Connected records

- cancers: [Borderline resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/borderline-resectable-pdac/), [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- drugs: [Capecitabine](https://onco.cc/drugs/capecitabine/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct02598349.json